Kezhong Zhang Selected Research

Inflammation (Inflammations)

1/2021	Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder.
10/2020	Toll-like receptor 2 (TLR2) engages endoplasmic reticulum stress sensor IRE1α to regulate retinal innate responses in Staphylococcus aureus endophthalmitis.
4/2019	PM2.5 exposure induces systemic inflammation and oxidative stress in an intracranial atherosclerosis rat model.
1/2019	HIF-1α regulates IL-1β and IL-17 in sarcoidosis.
1/2017	CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia.
1/2017	SM22α suppresses cytokine-induced inflammation and the transcription of NF-κB inducing kinase (Nik) by modulating SRF transcriptional activity in vascular smooth muscle cells.
10/2016	ER Stress-induced Inflammasome Activation Contributes to Hepatic Inflammation and Steatosis.
1/2013	Exposure to fine airborne particulate matter induces macrophage infiltration, unfolded protein response, and lipid deposition in white adipose tissue.
8/2009	ER stress controls iron metabolism through induction of hepcidin.
7/2008	From endoplasmic-reticulum stress to the inflammatory response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kezhong Zhang Research Topics

Disease

15	Parkinson Disease (Parkinson's Disease) 01/2021 - 12/2008
10	Inflammation (Inflammations) 01/2021 - 07/2008
10	Neoplasms (Cancer) 08/2020 - 02/2011
9	Insulin Resistance 01/2022 - 01/2012
6	Breast Neoplasms (Breast Cancer) 08/2020 - 01/2012
4	Obesity 01/2021 - 01/2018
4	Non-alcoholic Fatty Liver Disease 10/2020 - 03/2014
4	Acute-Phase Reaction 01/2017 - 02/2006
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2015 - 08/2003
2	Multiple System Atrophy 01/2021 - 09/2010
2	Glucose Intolerance 01/2021 - 01/2013
2	Vascular System Injuries 12/2020 - 01/2017
2	Dyskinesias (Dyskinesia) 01/2020 - 10/2019
2	Wounds and Injuries (Trauma) 01/2019 - 10/2016
2	Hyperglycemia 01/2019 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018 - 12/2015
2	Fatty Liver 10/2018 - 10/2016
2	Tremor (Tremors) 01/2018 - 01/2016
2	Hypertriglyceridemia 01/2016 - 03/2014
2	Diabetes Mellitus 01/2013 - 01/2012
2	Metabolic Diseases (Metabolic Disease) 01/2013 - 06/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2012 - 01/2012
2	Carcinogenesis 09/2012 - 06/2012
1	Chronic Disease (Chronic Diseases) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2021
1	Paralysis (Palsy) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	MELAS Syndrome (Syndrome, MELAS) 12/2020
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 10/2020
1	Endophthalmitis (Ophthalmia) 10/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Starvation 01/2019
1	Sarcoidosis (Schaumann Disease) 01/2019
1	Female Infertility 11/2018
1	Pancreatic Diseases (Pancreatic Disease) 01/2018
1	Stroke (Strokes) 01/2018
1	Hyperlipoproteinemias 01/2017

Drug/Important Bio-Agent (IBA)

14	LipidsIBA 01/2022 - 06/2010
12	Proteins (Proteins, Gene)FDA Link 12/2020 - 10/2008
6	Insulin (Novolin)FDA Link 01/2022 - 01/2012
6	EnzymesIBA 12/2021 - 01/2012
6	Transcription Factors (Transcription Factor)IBA 01/2019 - 02/2006
6	Carrier Proteins (Binding Protein)IBA 01/2017 - 10/2008
5	Particulate MatterIBA 01/2020 - 10/2010
4	Inositol (Myoinositol)IBA 12/2021 - 01/2018
4	ElementsIBA 01/2017 - 10/2008
3	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 01/2016
3	fibroblast growth factor 21IBA 11/2018 - 03/2014
3	IronIBA 01/2018 - 08/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2018
2	Phenobarbital (Luminal)FDA Link 08/2020 - 06/2012
2	EndoribonucleasesIBA 08/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 08/2020 - 03/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 06/2014
2	Pharmaceutical PreparationsIBA 10/2018 - 04/2011
2	CytokinesIBA 01/2017 - 09/2013
2	LipopolysaccharidesIBA 01/2017 - 10/2016
2	Lysine (L-Lysine)FDA Link 12/2015 - 01/2012
2	Biological ProductsIBA 06/2012 - 01/2012
2	Factor VIII (Coagulation Factor VIII)IBA 04/2011 - 11/2008
1	IsotopesIBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Monounsaturated Fatty AcidsIBA 12/2021
1	LaxativesIBA 11/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	SynucleinsIBA 01/2021
1	Toll-Like Receptor 3IBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 12/2020
1	Differentiation AntigensIBA 12/2020
1	Toll-Like Receptor 2IBA 10/2020
1	Retinaldehyde (Retinal)IBA 10/2020
1	GTP Phosphohydrolases (GTPases)IBA 08/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	OligosaccharidesIBA 01/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020
1	heparanaseIBA 01/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	hesperetinIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	ResveratrolIBA 01/2019
1	Hormones (Hormone)IBA 11/2018
1	Transferrin (beta 2 Transferrin)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	SirtuinsIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	mocetinostatIBA 01/2017
1	VLDL LipoproteinsIBA 01/2017
1	Apolipoproteins B (ApoB)IBA 01/2017

Therapy/Procedure

5	Therapeutics 01/2019 - 07/2008
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019